Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1963 Jul;42(7):1134–1141. doi: 10.1172/JCI104798

THE METABOLISM OF RING-LABELED L-THYROXINE-C14IN VIVO

C D West 1,2, E L Simons 1,2, M J Gortatowski 1,2, L F Kumagai 1,2
PMCID: PMC289381  PMID: 14000087

Full text

PDF
1134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FLOCK E. V., BOLLMAN J. L., GRINDLAY J. H., STOBIE G. H. Partial deiodination of 1-thyroxine. Endocrinology. 1961 Sep;69:626–637. doi: 10.1210/endo-69-3-626. [DOI] [PubMed] [Google Scholar]
  2. FLOCK E. V., BOLLMAN J. L. The metabolism of thyroxine and triiodothyronine in the eviscerated rat. J Biol Chem. 1955 Jun;214(2):709–721. [PubMed] [Google Scholar]
  3. FREDRICKSON D. S., ONO K. An improved technique for assay of C14O2 in expired air using the liquid scintillation counter. J Lab Clin Med. 1958 Jan;51(1):147–151. [PubMed] [Google Scholar]
  4. INGBAR S. H., FREINKEL N. Simultaneous estimation of rates of thyroxine degradation and thyroid hormone synthesis. J Clin Invest. 1955 Jun;34(6):808–819. doi: 10.1172/JCI103136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. KLITGAARD H. M., LIPNER H. J., BARKER S. B., WINNICK T. Pathways of elimination of C14-labeled thyroxine in the rat. Endocrinology. 1953 Jan;52(1):79–82. doi: 10.1210/endo-52-1-79. [DOI] [PubMed] [Google Scholar]
  6. KOT P. A., KLITGAARD H. M. Elimination of C14-labeled thyroxine in the bile, urine and expired air of rats in altered thyroid states. Endocrinology. 1959 Mar;64(3):319–325. doi: 10.1210/endo-64-3-319. [DOI] [PubMed] [Google Scholar]
  7. MONEY W. L., MELTZER R. I., FELDMAN D., RAWSON R. W. The effect of various thyroxine analogues on suppression of I 131 uptake by the rat thyroid. Endocrinology. 1959 Jan;64(1):123–125. doi: 10.1210/endo-64-1-123. [DOI] [PubMed] [Google Scholar]
  8. PLAMONDON C. A., SELENKOW H. A., WISWELL J. G., ASPER S. P., Jr Studies of thyroxine and some of its analogues. II. The antigoitrogenic properties of thyroxine and triiodothyronine. Bull Johns Hopkins Hosp. 1958 Feb;102(2):88–93. [PubMed] [Google Scholar]
  9. ROCHE J., MICHEL O., MICHEL R., TATA J. Sur l'élimination biliaire de la triiodothyronine et de la thyroxine et sur leur glycuroconjugaison hépatique. Biochim Biophys Acta. 1954 Apr;13(4):471–479. doi: 10.1016/0006-3002(54)90363-7. [DOI] [PubMed] [Google Scholar]
  10. ROCHE J., MICHEL R., CLOSON J., MICHEL O. Sur la sulfoconjugaison hépatique de la 3, 5, 3'-triiodo-L-thyronine et la présence d'un ester sulfurique de cette hormone dans la bile et la plasma. Biochim Biophys Acta. 1959 Jun;33(2):461–469. doi: 10.1016/0006-3002(59)90136-2. [DOI] [PubMed] [Google Scholar]
  11. ROCHE J., MICHEL R., TATA J. Sur la nature des combinaisons iodées excrétées par le foie et le rein après administration de L-thyroxine et de L-3:5:3'-triiodothyronine. Biochim Biophys Acta. 1954 Dec;15(4):500–507. doi: 10.1016/0006-3002(54)90007-4. [DOI] [PubMed] [Google Scholar]
  12. TAUROG A., BRIGGS F. N., CHAIKOFF I. L. I131-labeled L-thyroxine. I. An unidentified excretion product in bile. J Biol Chem. 1951 Jul;191(1):29–34. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES